Compound ID | 2809
Synonym(s): CDCHD
Class: Tetracycline
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, and Escherichia coli |
| Description: | Natural product from a genetically engineered strain of Amycolatopsis sulphurea containing combined genes from chelocardin and oxytetracycline biosynthetic gene clusters; atypical tetracycline; demonstrates efficacy in ascending urinary tract infection model (10-fold lower doses compared to gentamicin); overcomes tetracycline resistance |
| Institute where first reported: | Department of Microbial Natural Products, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI) and Department of Pharmacy, Saarland University Campus, Saarbrücken, Germany; German Centre for Infection Research (DZIF), Partner Site Braunschweig-Hannover, Braunschweig, Germany |
| Year first mentioned: | 2015 |
| Development status: | Experimental |